Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/24/2004 | CN1176692C Specially effective Chinese medicine for liver disease and preparation process |
11/24/2004 | CN1176691C Medicine for treating rheumatic and rheumatoid disease and its preparation method |
11/24/2004 | CN1176684C Medicine 'Jiwenning' for treating chicken pest and its preparing process |
11/24/2004 | CN1176683C Medicine for treating hepatitis B and other hepatosis and its preparing method |
11/24/2004 | CN1176682C Medicine for treating pulmonary tuberculosis and its preparing process |
11/24/2004 | CN1176664C Medicine for treating bacillary dysentery and enteritis |
11/24/2004 | CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use |
11/24/2004 | CN1176657C Drug composition containing cefazolin and beta-lactamase inhibitor |
11/24/2004 | CN1176655C Refapentine or rifampin liposome perfusate, injection and preparation process thereof |
11/24/2004 | CN1176651C N-(3-benzofuryl) urea derivative |
11/23/2004 | US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
11/23/2004 | US6822097 Compounds and methods of uses |
11/23/2004 | US6821998 Arylamines as inhibitors of chemokine binding to US28 |
11/23/2004 | US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants |
11/23/2004 | US6821984 Ring fused pyrazole derivatives as CRF antagonists |
11/23/2004 | US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines |
11/23/2004 | US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia |
11/23/2004 | US6821969 Thioxazinoquinolones as antiviral agents |
11/23/2004 | US6821966 Antiinflammatory agents |
11/23/2004 | US6821965 Important in disease or medical conditions such as inflammation and immunoregulation |
11/23/2004 | US6821951 An echinocandin/carbohydrate complex in an oral formulation to enhance heat resistance/shelf life; desolventizing a solution of an echinocandin or echinocandin/carbohydrate complex and a carbohydrate sprayed on a carrier; fungicides |
11/23/2004 | US6821754 Staphylococcus aureus genes and polypeptides |
11/23/2004 | US6821723 Polypeptide mimics the intermediate state of gp41 and is capable of inducing antibodies which neutralize primary isolates of hiv |
11/23/2004 | US6821549 Contacting stent with a coating solution containing a coating material to be deposited on surface of stent; inserting thread through the lumen of the stent; producing relative motion between stent and thread to remove coating material |
11/23/2004 | US6821521 Multicomponent meningococcal vaccine |
11/23/2004 | US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant |
11/23/2004 | US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine) |
11/23/2004 | US6821394 Process of extracting from haw-pit by dry distillation and its device |
11/23/2004 | CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases |
11/23/2004 | CA2317106C Method and composition of an oral preparation of itraconazole |
11/23/2004 | CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor |
11/23/2004 | CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides |
11/23/2004 | CA2135768C Indolocarbazole imides and the use thereof |
11/23/2004 | CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts |
11/23/2004 | CA2012482C Hepatitis c diagnostics and vaccines |
11/18/2004 | WO2004099212A1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
11/18/2004 | WO2004099199A1 Oxazolidinone derivatives as antimicrobials |
11/18/2004 | WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
11/18/2004 | WO2004099175A2 Blockers of the quorum sensing system of gram-negative bacteria |
11/18/2004 | WO2004098640A1 Use of combinations of reverse transcriptase inhibitors and virus coded dna polymerase inhibitors |
11/18/2004 | WO2004098636A2 Vaccinating against infectious diseases using proteosomes |
11/18/2004 | WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2) |
11/18/2004 | WO2004098500A2 CARBACEPHEM ss-LACTAM ANTIBIOTICS |
11/18/2004 | WO2004098491A2 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
11/18/2004 | WO2004073613A3 A medicine and food |
11/18/2004 | WO2004069998A3 Oxindole derivatives as antimicrobial agents |
11/18/2004 | WO2004065601A3 Lipophilic derivatives of double-stranded ribonucleic acid |
11/18/2004 | WO2004063160A8 Novel quaternary ammonium salt compound having antibacterial activity and process for producing the same |
11/18/2004 | WO2004062686A3 Therapeutic use of modulators of notch |
11/18/2004 | WO2004054603A3 Use of beta-defensins for treating hiv infections |
11/18/2004 | WO2003076591A8 Compositions and methods for generating an immune response |
11/18/2004 | WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents |
11/18/2004 | WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/18/2004 | WO2002086087A3 Cytokine protein family |
11/18/2004 | US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
11/18/2004 | US20040230037 Chemokine receptor materials and methods |
11/18/2004 | US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
11/18/2004 | US20040229909 Antiviral agent |
11/18/2004 | US20040229903 4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure |
11/18/2004 | US20040229897 Aid in cytokine biosynthesis |
11/18/2004 | US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists |
11/18/2004 | US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract |
11/18/2004 | US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
11/18/2004 | US20040229843 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
11/18/2004 | US20040229835 Immunostimulatory nucleic acid molecules |
11/18/2004 | US20040229831 Compositions and methods for non-parenteral delivery of oligonucleotides |
11/18/2004 | US20040229828 Administering a therapeutically effective amount of at least one pharmacologically acceptable oligonucleotide at least 10 nucleotides in length |
11/18/2004 | US20040229823 For use in therapy of growth metabolic disorders |
11/18/2004 | US20040229818 Hepatitis C inhibitor compound |
11/18/2004 | US20040229817 Inhibitors of Hepatitis C virus, compositions and treatments using the same |
11/18/2004 | US20040229809 Immunogenic peptides from the HPV E7 protein |
11/18/2004 | US20040229801 Provides anti-fungal compounds, including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity, and methods of using the compounds for killing or inhibit growth of yeast, mold, slimes |
11/18/2004 | US20040229795 For oncological diseases and diseases accompanying neovascularization, immune complex-mediated and autoimmune diseases, viral infections, fibrotic and granulomatous diseases, allergic diseases, degenerative diseases of the nervous system and arteriosclerosis |
11/18/2004 | US20040229778 Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
11/18/2004 | US20040229775 Bactericide drug |
11/18/2004 | US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants |
11/18/2004 | US20040229266 RNA interference mediating small RNA molecules |
11/18/2004 | US20040229212 Recombinant human mannan-binding lectin |
11/18/2004 | US20040228889 Use of N-arylmethylene ethylenediaminetriacetates, N-arylmethylene iminodiacetated or N,N'-diarylmethylene ethylenediamineacetates as doners of NO |
11/18/2004 | US20040228879 Streptococcus pneumoniae polysaccharide is conjugated to protein or peptide, and RSV antigen with adjuvant which is stimmulator of (cytotoxic T) lymphocytes |
11/18/2004 | US20040228877 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
11/18/2004 | US20040228876 Composition and Method for Treating Cancer Using Herpes Virus |
11/18/2004 | US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease |
11/18/2004 | US20040228840 Vector for integration of heterologous sequences into poxviral genomes |
11/18/2004 | US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
11/18/2004 | US20040228804 Preventing the occurrence of respiratory infections, shipping fever during shipping the cattles, by misting the nose with a solution containing adonitol |
11/18/2004 | US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
11/18/2004 | DE10319612A1 Substituierte Dihydrochinazoline Substituted dihydroquinazolines |
11/18/2004 | CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria |
11/18/2004 | CA2526875A1 Carbacephem beta-lactam antibiotics |
11/18/2004 | CA2524799A1 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
11/18/2004 | CA2524485A1 Vaccinating against infectious diseases using proteosomes |
11/18/2004 | CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof |
11/18/2004 | CA2504493A1 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
11/17/2004 | WO2004107200A1 System and method for controlling user interface properties with data |
11/17/2004 | EP1477563A2 Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use |
11/17/2004 | EP1477494A1 Subunit respiratory syncytial virus vaccine preparation |
11/17/2004 | EP1477486A2 Imides as inhibitors of TNF alpha |
11/17/2004 | EP1477479A1 Process for the preparation of the D-(-)-tartrate salt of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanol |
11/17/2004 | EP1477187A1 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |